Epidemiological characteristics and obstetric complications in pregnant women diagnosed with COVID-19 in a public hospital
Keywords:
COVID-19, SARS-CoV-2, pregnancy outcome, epidemiological profile, pregnancy.Abstract
Introduction: COVID-19 in pregnant women has been a challenge in maternal care, since it could increase the risk of suffering from some obstetric diseases and negative perinatal results.Objective: To describe the epidemiological characteristics and obstetric complications in pregnant women diagnosed with COVID-19.
Methods: Descriptive, and cross-sectional study, carried out in a sample of 235 pregnant women with a diagnosis of COVID-19, selected in a non-random way. Epidemiological characteristics and obstetric complications were studied, which were reported by descriptive statistics in univariate tables.
Results: The average age of the pregnant women was 27.6 ± 3.7 years, 65.5 % were cohabiting and 77.4 % had secondary education. In addition, 71.5 % were between 37 and 40 weeks' gestation, 28.5 % had no prenatal care, 68.9 % were multi-pregnant, and 27.7 % had a history of abortion; 90.6 % were asymptomatic and headache was the most frequent symptom (7.4 %). Among obstetric complications, 30.6 % had a cesarean birth, 20 % had anemia and 15.7 % premature rupture of the membrane. Hellp syndrome (0.9 %) and eclampsia (0.4 %) were the least frequent.
Conclusions: In pregnant women with COVID-19 there is a high rate of obstetric complications, which are mainly caesarean section and anemia. Most pregnant women are asymptomatic and have an IgM / IgG serological result.
Downloads
References
2. Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, iao AH. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol. 2020 [acceso: 27/07/2021]; 84(5): e13304. Disponible en: https://doi.org/10.1111/aji.13304
3. Wastnedge E, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021 [acceso: 27/07/2021]; 101(1): 303-318. Disponible en: https://doi.org/10.1152/physrev.00024.2020d
4. Haizler-Cohen L, Davidov A, Blitz MJ, Fruhman G. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units. Am J Obstet Gynecol. 2021 [acceso: 27/07/2021]; 224(1): 112-14. Disponible en: https://doi.org/10.1016/j.ajog.2020.09.022
5. Savirón-Cornudella R, Villalba A, Zapardiel J, Andeyro-Garcia M, Esteban LM, Pérez-López FR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery. Eur J Obstet Gynecol Reprod Biol. 2021 [acceso: 28/07/2021]; 256: 400-4. Disponible en: https://doi.org/10.1016/j.ejogrb.2020.11.069
6. Organización Panamericana de la Salud / Organización Mundial de la Salud. Actualización epidemiológica: Enfermedad por Coronavirus (COVID-19). 22 de julio de 2021, Washington, D.C.: OPS/OMS; 2021 [acceso: 29/07/2021]. Disponible en: https://www.paho.org/es/file/92055/download?token=3nPUqnh4
7. Vera E, Montenegro I, Marcelo H, Arce M, Cruzate V, Pelaez M. Gestación en tiempos de pandemia COVID 19. Hospital Nacional Docente Madre Niño San Bartolomé, Lima, Perú. Rev Peru Ginecol Obstet. 2020 [acceso: 24/06/2021]; 66(3): [aprox. 5 pant.]. Disponible en: https://doi.org/10.31403/rpgo.v66i2265
8. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021 [acceso: 26/06/2021];193(16): E540-E548. Disponible en: https://doi.org/10.1503/cmaj.202604
9. Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020 [acceso: 26/06/2021];25(1):39. Disponible en: https://doi.org/10.1186/s40001-020-00439-w
10. Marín MA, Reyne M, Caserío S, Sole L, Carrizosa T, Rivero I, et al. Maternal, Perinatal and Neonatal Outcomes With COVID-19: A Multicenter Study of 242 Pregnancies and Their 248 Infant Newborns During Their First Month of Life. Pediatr Infect Dis J. 2020 [acceso: 15/07/2021]; 39(12): e393-e397. Disponible en: https://doi.org/10.1097/INF.0000000000002902
11. Di Guardo F, Di Grazia FM, Di Gregorio LM, Zambrotta E, Carrara G, Gulino FA, et al. Poor maternal-neonatal outcomes in pregnant patients with confirmed SARS-Cov-2 infection: analysis of 145 cases. Arch Gynecol Obstet. 2021 [acceso: 20/07/2021]; 303: 1483-1488. Disponible en: https://doi.org/10.1007/s00404-020-05909-4
12. Huerta IH, Elías JC, Campos K, Muñoz R, Coronado JC. Características materno perinatales de gestantes COVID-19 en un hospital nacional de Lima, Perú. Rev Peru Ginecol Obstet. 2020 [acceso: 25/07/2021]; 66(2): 00003. Disponible en: http://dx.doi.org/10.31403/rpgo.v66i2245
13. Timircan M, Bratosin F, Vidican I, Suciu O, Tirnea L, Avram V, et al. Exploring Pregnancy Outcomes Associated with SARS-CoV-2 Infection. Medicina. 2021 [acceso; 10/07/2021]; 57: 796. Disponible en: https://doi.org/10.3390/medicina57080796
14. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021 [acceso: 30/07/2021]; 175(8):817-826. Disponible en: https://doi.org/10.1001/jamapediatrics.2021.1050
15. Dávila-Aliaga C, Hinojosa-Pérez R, Espinola-Sánchez M, Torres-Marcos E, Guevara-Ríos E, Espinoza-Vivas Y, et al. Resultados materno-perinatales en gestantes con COVID-19 en un hospital nivel III del Perú. Rev Peru Med Exp Salud Publica. 2021 [acceso: 30/07/2021]; 38(1):58-63. Disponible en: https://doi.org/10.17843/rpmesp.2021.381.6358
16. Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021 [acceso: 25/07/2021]; 225(3):289.e1-289.e17. Disponible en: https://doi.org/10.1016/j.ajog.2021.05.014
17. Singh V, Choudhary A, Datta MR, Ray A. Maternal and Neonatal Outcomes of COVID-19 in Pregnancy: A Single-Centre Observational Study. Cureus. 2021 [acceso: 26/07/2021]; 13(2):e13184. Disponible en: https://doi.org/10.7759/cureus.13184
18. Yang R, Mei H, Zheng T, Fu Q, Zhang Y, Buka S, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC Med. 2020 [acceso: 17/07/2021]; 18:330. Disponible en: https://doi.org/10.1186/s12916-020-01798-1
19. Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020 [acceso: 04/08/2021]; 127(12):1548-56. Disponible en: https://doi.org/10.1111/1471-0528.16403
20. Zlochiver V, Tilkens B, Perez AC, Aziz F, Jan MF. COVID-19 Deliveries: Maternal Features and Neonatal Outcomes. J Patient Cent Res Rev. 2021 [acceso: 04/08/2021]; 8(3):286-289. https://doi.org/10.17294/2330-0698.1848
21. Mullins E, Hudak ML, Banerjee J, Getzlaff T, Townson J, Barnette K, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021 [acceso: 05/08/2021]; 57(4):573-581. Disponible en: https://doi.org/10.1002/uog.23619
22. Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PloS One. 2021 [acceso: 05/08/2021]; 16(5):e0251123. Disponible en: https://doi.org/10.1371/journal.pone.0251123
Published
How to Cite
Issue
Section
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.